New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

Ocular AEs linked to mirvetuximab soravtansine do not appear to reduce HRQOL in patients with FRα+ platinum-resistant ovarian cancer.

本研究针对氮芥诱导的角膜缘干细胞缺乏症（LSCD），开发出一种基于类脂蛋白纳米颗粒（HDL NP）的新型疗法，显著改善角膜混浊、减轻炎症反应，有望成为治疗 mustard keratopathy 及其他慢性角膜炎性疾病的有效手段。

In addition to aniridia and neurotrophic keratopathy, RESTORE VISION is studying five other rare diseases affecting the ocular surface: ocular cicatricial pemphigoid, an autoimmune disease that ...